US Patent Issued to UNIVERSITEIT ANTWERPEN on July 7 for "Limosilactobacillus reuteri strain with high riboflavin production and uses thereof" (Belgian Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,674,188, issued on July 7, was assigned to UNIVERSITEIT ANTWERPEN (Antwerp, Belgium).

"Limosilactobacillus reuteri strain with high riboflavin production and uses thereof" was invented by Sarah Lebeer (Antwerp, Belgium), Sarah Ahannach (Antwerp, Belgium), Irina Spacova (Antwerp, Belgium) and Stijn Wittouck (Antwerp, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention to the identification of a novel isolated bacterial strain, the Limosilactobacillus reuteri strain which is characterized by a naturally occurring overproduction of riboflavin (vitamin B2) compared to other known strains of lactobacilli. Said strain of the Limosilact...